Burosumab for the Treatment of Tumor‐Induced Osteomalacia-Reference-Cited by-同舟云学术

Burosumab for the Treatment of Tumor‐Induced Osteomalacia

Published:2021-01-12 Issue:4 Volume:36 Page:627-635
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Jan de Beur Suzanne M¹,Miller Paul D²,Weber Thomas J³,Peacock Munro⁴,Insogna Karl⁵^ORCID,Kumar Rajiv⁶,Rauch Frank⁷,Luca Diana⁸,Cimms Tricia⁸,Roberts Mary Scott⁸,San Martin Javier⁸,Carpenter Thomas O⁵

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore MD USA

2. Colorado Center for Bone Research Lakewood CO USA

3. Duke University Durham NC USA

4. Indiana University School of Medicine Indianapolis IN USA

5. Yale University School of Medicine New Haven CT USA

6. Mayo Clinic College of Medicine Rochester MN USA

7. McGill University Montreal Canada

8. Ultragenyx Pharmaceutical Inc. Novato CA USA

Funder

Ultragenyx Pharmaceutical

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4233

Reference30 articles.

1. Tumour-induced osteomalacia

2. Tumor localization and biochemical response to cure in tumor-induced osteomalacia

3. Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

4. Burosumab: First Global Approval

5. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extended curettage for tumour-induced osteomalacia in the bone;Japanese Journal of Clinical Oncology;2024-01-23

2. Treatment and Diagnose of Spinal Phosphaturic Mesenchymal Tumor: A Case Report and a Systematic Literature Review;World Neurosurgery;2024-01

3. Clinical disorders of phosphate homeostasis;Feldman and Pike's Vitamin D;2024

4. Fibrous dysplasia in children and its management;Current Opinion in Endocrinology, Diabetes & Obesity;2023-11-27

5. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia;The Journal of Clinical Endocrinology & Metabolism;2023-11-25